Skip to Content
Serving All of Western New York

Settlement Reached in Stryker Rejuvenate/ABG II Modular Hip Implant Litigation


At a late afternoon court conference on November 3, 2014, New Jersey Judge Brian Martinotti announced that a global settlement was reached in the Stryker Rejuvenate/ABG II Modular Hip Implant Litigation.  Stryker has set aside $1.425 billion to settle the claims against it related to the failure of these hip implant systems.

Per the terms of the Master Settlement Agreement, plaintiffs and claimants who had a "Qualified Revision Surgery" before November 3, 2014 can enroll in the settlement program. The base award for a qualified claimant who underwent revision surgery is $300,000 subject to a possible reduction for age.  In addition, in certain circumstances a plaintiff may be eligible to apply for an enhanced award.  Stryker retains the right to exercise walk away rights by June 15, 2015 if a 95% participation rate is not met.  For more information on the settlement and to read the Master Settlement Agreement, please go to

Faraci Lange represents several clients that were forced to undergo revision surgery to remove their defective Stryker Rejuvenate or ABG II hip implants. If you received a Stryker Rejuvenate or ABG II implant, please contact us to discuss your legal rights.

Share To: